How HIV Evades the Immune System: Antigenic Variation and MHC-I Downregulation
HIV employs sophisticated mechanisms to avoid detection and elimination by the host immune system. Two major strategies underpin its ability to establish chronic infection.
1. Antigenic Variation
HIV rapidly mutates its envelope glycoprotein (gp120), the primary target of neutralizing antibodies. This constant structural change allows the virus to escape antibody recognition, leading to persistent infection despite ongoing immune responses.
2. Downregulation of MHC-I Molecules
HIV proteins (particularly Nef) reduce expression of major histocompatibility complex class I (MHC-I) on infected cells. MHC-I presents viral peptides to cytotoxic T lymphocytes (CTLs). By downregulating MHC-I, HIV-infected cells become less visible to CTLs, evading cell-mediated immunity.
Consequences
These mechanisms contribute to HIV's ability to establish chronic infection, complicate vaccine development, and necessitate lifelong antiretroviral therapy for viral suppression.
HIV & AIDS - Related Articles
- Repeat Pap Smear & HIV Testing: Indications, Guidelines & Integration
- How HIV Attacks the Immune System: Understanding AIDS and Immunodeficiency
- Understanding the Disparity: AIDS Prevalence in Africa vs. Canada
- Thrush: Symptoms, Causes, and When to See a Doctor
- Strep Throat Transmission: Can Your Partner Spread It to Others?
- HIV Prevalence in Southern and Eastern Africa: 2021 Epidemiologic Snapshot
- Understanding HIV Positive Status: What You Need to Know
